For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status, an immune checkpoint inhibitor drug called durvalumab is safe and may benefit overall survival, according to a new ...
Nov 21, 2023
0
37
Queen Mary University of London researchers have discovered a new immune mechanism in osteocytes, the most common type of bone cell, that could lead to new drugs for breast and prostate cancer.
Nov 17, 2023
0
35
Advances in childhood cancer are a success story in modern medicine. But in the past decade, those strides have stalled for Black and Hispanic youth, opening a gap in death rates, according to a new report published Thursday.
Nov 16, 2023
17
0
While the overall cancer death rate has been steadily declining in the U.S. since the 1990s, death rates due to pancreatic cancer are increasing.
Nov 8, 2023
0
0
New research from India has shown how machine learning, colloquially known as artificial intelligence or AI, could improve the early detection of skin cancer. Given that the incidence of skin cancer is on the rise, the work, ...
Nov 2, 2023
0
0
The incidence of thyroid cancer in São Paulo State, part of Brazil's relatively developed Southeast region, varies considerably according to socioeconomic status (education, poverty, wealth, income, segregation, mobility, ...
Oct 31, 2023
0
0
Patients with ovarian cancer are 70% less likely to die three years after a multidisciplinary surgical approach is deployed, according to new research. The study from the Mater University Hospital on treating advanced ovarian ...
Oct 30, 2023
0
0
It may be surprising to hear, but medically speaking, not all stress is bad. Healthy stress levels help build resilience, says Safia Debar, MBBS, a stress management expert at Mayo Clinic Healthcare in London. In this expert ...
Oct 26, 2023
0
2
An old campaign slogan for cough syrup, "It tastes awful. And it works," seemed to imply that any sweet content might have diminished the medicinal effect.
Oct 26, 2023
0
0
A new study has revealed that Metixene, an antiparkinsonian drug, has shown remarkable potential as a novel treatment for metastatic breast cancer and brain metastases, providing hope for patients facing this devastating ...
Oct 23, 2023
0
0
